Association of follicle-stimulating hormone and sex hormone binding globulin with the metabolic syndrome in postmenopausal women

Clinical Biochemistry

Volumn 45, Issue 9, 2012, Pages 703-706

  Stefanska, Anna ^a   Sypniewska, Grazyna ^a   Ponikowska, Irena ^a   Cwiklinska Jurkowska, Malgorzata ^b  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Follicle stimulating hormone; Menopause; Metabolic syndrome; Sex hormone binding globulin

Indexed keywords

FOLLITROPIN; SEX HORMONE BINDING GLOBULIN;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; POSTMENOPAUSE; PRIORITY JOURNAL;

CASE-CONTROL STUDIES; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LIPIDS; LOGISTIC MODELS; METABOLIC SYNDROME X; MIDDLE AGED; POSTMENOPAUSE; ROC CURVE; SEX HORMONE-BINDING GLOBULIN;

EID: 84861230122     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.03.011     Document Type: Article

References (12)

1. Lee C.C., Kasa-Vubu J.Z., Supiano M.A. Androgenicity and obesity are independently associated with insulin sensitivity in postmenopausal women. Metabolism 2004, 53:507-512.
2. Akin F., Bastemir M., Alkis E. Effect of insulin sensitivity on SHBG levels in premenopausal versus postmenopausal obese women. Adv Ther 2007, 24:1210-1220.
3. Akin F., Bastemir M., Alkiş E., Kaptanoglu B. SHBG levels correlate with insulin resistance in postmenopausal women. Eur J Intern Med 2009, 2:162-167.
4. Dandona P., Dhindsa S. Update: hypogonadotropic hypogonadism in type 2 diabetes and obesity. J Clin Endocrinol Metab 2011, 96:2643-2651.
5. Castelo-Branco C., Steinvarcel F., Osorio A., Ros C., Balasch J. Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism. Gynecol Endocrinol 2010, 26:736-742.
6. Turcato E., Zamboni M., De Pergola G., Armellini F., Zivelonghi A., Bergamo-Andreis I.A., et al. Interrelationships between weight loss, body fat distribution and sex hormones in pre- and postmenopausal obese women. J Intern Med 1997, 241:363-372.
7. Bjørnerem A., Straume B., Midtby M., Fønnebø V., Sundsfjor J., Svartberg J., et al. Endogenous sex hormones in relation to age, sex, lifestyle factors, and chronic diseases in a general population: the Tromsø Study. J Clin Endocrinol Metab 2004, 89:6039-6047.
8. Malacara J.M., Fajardo M.E., Nava L.E. Gonadotropins at menopause: the influence of obesity, insulin resistance, and estrogens. Steroids 2001, 66:559-567.
9. Alberti K.G., Zimmet P., Shaw J. Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006, 23:469-480.
10. Velasco E., Malacara J.M., Cervantes F., de León J.D., Dávalos G., Castillo J. Gonadotropins and prolactin serum levels during the perimenopausal period: correlation with diverse factors. Fertil Steril 1990, 53:56-60.
11. Weinberg M.E., Manson J.E., Buring J.E., Cook N.R., Seely E.W., Ridker P.M., et al. Low sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women. Metabolism 2006, 55:1473-1480.
12. Hajamor S., Després J.P., Couillard C., Lemieux S., Tremblay A., Prud'homme D., et al. Relationship between sex hormone-binding globulin levels and features of the metabolic syndrome. Metabolism 2003, 52:724-730.